Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours

Clinical Endocrinology

Volumn 49, Issue 4, 1998, Pages 475-482

  De Keyzer, Y ^a,c   Rene P ^a   Beldjord, C ^b   Lenne, F ^a   Bertagna, X ^a  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; PROOPIOMELANOCORTIN; VASOPRESSIN V3 RECEPTOR;

ARTICLE; BRONCHUS CARCINOID; CONTROLLED STUDY; CORTICOTROPIN RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; RECEPTOR GENE;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; GENE EXPRESSION; HUMANS; PITUITARY GLAND; PITUITARY NEOPLASMS; PRO-OPIOMELANOCORTIN; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031670782     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00560.x     Document Type: Article

References (41)

1. Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B. & Joubert, D. (1993) Invasive human pituitary tumors express a point-mutated a-protein kinase C. Journal of Clinical Endocrinology and Metabolism, 77, 1125-1129.
2. Bertagna, X., Raux-Demay, M.C., Guilhaume, B., Girard, F. & Luton, J.P. (1995) Cushing's disease. In Cushing's Disease (ed. S. Melmed). pp. 478-545. Blackwell Science Inc., Ann-Arbor MI.
3. Blumberg, P.M., Acs, G., Areces, L.B., Kazanietz, M.G., Lewin, N.E. & Szallasi, Z. (1994) Protein kinase C in signal transduction and carcinogenesis. Progress in Clinical and Biological Research, 387, 3-19.
4. Cavalho, P. & Aguilera, G. (1989) Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs. Molecular Endocrinology, 3, 1935-1943.
5. Chen, R., Lewis, K.A., Perrin, M.H., & Vale, W.W. (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proceedings of the National Academy of Sciences USA, 90, 8967-8971.
6. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in rihonucleases. Biochemistry, 18, 5295-5299.
7. Clemens, M.J., Trayner, I. & Menaya, J. (1992) The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. Journal of Cell Sciences, 103, 881-887.
8. Colao, A., Ferone, D., Di Sarno, A., Tripodi, F.S., Marzullo, P., Boudouresque. F., Oliver, C., Merola, B. & Lombardi. G. (1996) Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease. Clinical Endocrinology, 45, 157-166.
9. Dahia, P.L.M., Ahmed-Shuaib, A., Jacobs, R.A., Chew, S.L., Honegger, J., Fahlbusch, R., Besser, G.M. & Grossman, A.B. (1996) Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism, 81, 1768-1771.
10. de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X. & Clauser. E. (1994) Cloning and characterization of the human V3 pituitary vasopressin receptor. Federation of European Biochemical Societies Letters, 356, 215-220.
11. de Keyzer, Y., Bertagna, X., Lenne, F., Girard, F., Luton, J.-P. & Kahn, A. (1985) Altered proopiomelanocortin gene expression in adrenocorticotropin-producing non-pituitary tumors. Journal of Clinical Investigation, 76, 1892-1898.
12. de Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J.-M., Luton, J.-P., Clauser, E. & Bertagna, X. (1996) The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical Investigation, 97, 1311-1318.
13. Dickstein, G., DeBold, C.R., Gaitan, D., DeCherney, G.S., Jackson, R.V., Sheldon, W.R.J., Nicholson, W.E. & Orth, D.N. (1996) Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 81, 2934-2941.
14. Fernandez, E., Bienvenu, T., Descalux-Arramond, F., Beldjord, K., Kaplan, J.C. & Beldjord, C. (1993) Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent mediterranean β-thalassemic mutations. PCR Methods and Applications, 3, 122-124.
15. Friedman, T.C., Yanovski, J.A., Nieman, L.K., Doppman, J.L., Cutler, G.B., Oldfteld, E.H., Gold, P.M., Chrousos, G.P. & Kalogeras, K.T. (1996) Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 81, 3068-3072.
16. Fukata, J., Shimizu, N., Imura, H., Hibi, I., Tanaka, K., Tanaka, T., Nakagawa, S., Takebe, K., Kimura, K., Yoshinaga, K., Takakura, K., Demura, H., Irie, M., Migacht, Y., Yanaihara, N., Yoshimi, T., Miura, K., Kuwayama, A., Ota, Z., Kato, Y., Saito, S., Takahara, J., Hashimoto, K., Nawata, H. & Matsukura, S. (1993) Human corticotrophin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders. Endocrine Journal, 40, 597-606.
17. Giguère, V. & Labrie, F. (1982) Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture. Endocrinology, 111, 1752-1754.
18. Gillies, G.E., Linton, E.A. & Lowry, P.J. (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature, 299, 355-357.
19. Kasagi, Y., Suda, T., Horiba, N., Ohmori, N., Tozawa, F., Dobashi, I. & Demura, H. (1994) DDAVP stimulation test for the diagnosis of ACTH-dependent Cushing's syndrome. Proceedings from the 76th Annual Meeting of the Endocrine Society, Anaheim, CA, USA. Abstract 508.
20. Kuhn, J.M., Proeschel, M.F., Seurin, D., Bertagna, X., Luton, J.P. & Girard, F. (1989) Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow up of patients with Cushing's syndrome. American Journal of Medicine, 86, 678-684.
21. Lamberts, S.W.J., Verleun, T., Oosterom, R., de Jong, F. & Hackeng, W.H.L. (1984) Corticolrophin releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. Journal of Clinical Endocrinology and Metabolism. 58, 298-303.
22. Landis, C.A., Master, S.B., Spada, A., Pace, A.M., Bourne, H.R. & Vallar, L. (1989) GTPase inhibition mutations activate the α chain of Gs and stimulate adenyl cyclase in human pituitary tumors. Nature, 340, 692-696.
23. Lyons, J., Landis, C.A. & Harsh, G. (1990) Two G-protein oncogenes in human endocrine tumors. Science, 249, 655-659.
24. Milano, C.A., Allen, L.F., Rockman, P.C., Dolber, P.C., McMinn, T.R., Chien, K.R., Johnson, R.A., Bond, R.A. & Lefkowitz, R.J. (1994) Enhanced myocardial function in transgenic mice overexpressing the β2 adrenergic receptor. Science, 264, 582-584.
25. Noh, D.Y., Shin, S.H. & Rhee, S.O. (1995) Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochimica Biophysica Acta. 1242, 99-113.
26. Newell-Prite, J., Perry, L., Medhak, S., Monson, J., Savage, M., Besser, M. & Grossman, A. (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 176-181.
27. Parma, J., Duprez, L., Van Sande, J., Cochaux, P., Gervy, C., Mokel, J., Dumont, J. & Vassart, G. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctionning thyroid adenomas. Nature, 365, 649-651.
28. 2+ cascades. Molecular Endocrinology, 9, 725-733.
29. Pieters, G.F.F., Hermus, A.R.M., Smals, A.G.H., Bartelink, A.K.M., Benraad, T.J. & Kloppenborg, P.W.C. (1983) Responsiveness of the hypophyseal-adrenocortical axis to corticotropin releasing factor in pituitary-dependent Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 57, 513-516.
30. Prévostel, C., Alvaro, V., de Boisvilliers, F., Martin, A., Jaffiol, C. & Joubert. D. (1995) The natural protein kinase Ca mutant is present in human thyroid neoplasms. Oncogene, 11, 669-674.
31. Rabadan-Diehl, C., Makara, G., Kiss, A.. Lolait, S., Zelena, D., Ochedalski, T. & Aguilera, G. (1997) Regulation of pituitary VIb vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. Endocrinology, 138, 5189-5194.
32. Raux, M.C., Binoux, M., Luton, J.P., Pham Huu Trung, M.T. & Girard, F. (1975) Studies of ACTH secretion control in 116 cases of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 40, 186-197.
33. Raymond, V., Leung, P.C.K., Veilleux, R. & Labrie, F. (1985) Vaso-pressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. Federation of European Biochemical Societies Letters, 182, 196-200.
34. Soloveva, V., Graves, R.A., Rasenick, M.M., Spiegelman, B.M. & Ross, S.R. (1997) Transgenic mice overexpressing the β1 -adrenergic receptor in adipose tissue are resistant to obesity. Molecular Endocrinology, II, 27-38.
35. Suarez, H.G., du Villard, J.A., Caillou, B., Schlumberger, M., Parmentier, C. & Monier, R. (1991) gsp mutations in human thyroid tumors. Oncogene, 6, 677-679.
36. Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S. & Kawashima, H. (1994) Molecular cloning and functional expression of a cDNA encoding the human VIb vasopressin receptor. Journal of Biological Chemistry, 269, 27088-27092.
37. Thihonnier, M., Preston, J.A., Dulin, N., Wllkins, P.L., Berti-Mattera, L.N. & Mattera, R. (1997) The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology, 138, 4109-4122.
38. Trouillas, J., Guigard, M.P., Fonlupt, P., Souchier, C. & Girod, C. (1996) Mapping of corticotropic cells in the normal human pituitary. Journal of Histochemistry and Cytochemistry, 44, 473-479.
39. Vallar, L., Spada, A. & Giannattasio, G. (1987) Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature, 330, 566-568.
40. Weinstein, L.S., Shenker, A., Gejman, P.V., Merino, M.J., Friedman, E. & Spiegel, A.M. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New England Journal of Medicine, 325, 1688-1695.
41. Wittert, G.A., Crock, P.A., Donald, R.A., Gilford, E.J., Boolell, M., Alford, F.P. & Espiner. E.A. (1990) Arginine vasopressin in Cushing's disease. Lancet, 335, 991-994.